DocGo

DCGO · NASDAQ

$0.2591+$0.0042 (+1.65%)TodayMarket closed ·
Prev close $0.2549

Latest news

  • Press releaseBusiness Wire

    DocGo Announces Upcoming Webinar to Outline Vision and Details of the Pending Hicuity Health Acquisition

  • Press releaseBusiness Wire

    DocGo Announces Upcoming Participation at Morgan Stanley 24th Annual Global Healthcare Conference

  • News

    12 Health Care Stocks Moving In Tuesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • News

    Transcript: DocGo Q2 2026 Earnings Conference Call

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • Press releaseBusiness Wire

    DocGo Announces Second Quarter 2026 Results

  • NewsAvi Kapoor

    DocGo Likely To Report Narrower Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • Press releaseBusiness Wire

    DocGo to Announce Second Quarter 2026 Results on Monday, August 17, 2026

  • Press releasePRNewswire

    Did DocGo Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • Press releaseBusiness Wire

    DocGo Launches Mobile Phlebotomy Services in South Florida

  • Press releaseBusiness Wire

    DocGo Announces Upcoming Participation at the Goldman Sachs 47th Annual Global Healthcare Conference

  • Press releaseBusiness Wire

    DocGo Announces First Quarter 2026 Results

  • News

    Earnings Scheduled For May 11, 2026

  • Press releaseBusiness Wire

    DocGo Announces Upcoming Participation at the 21st Annual Needham Technology, Media, & Consumer Conference

  • Press releaseBusiness Wire

    DocGo to Announce First Quarter 2026 Results on Monday, May 11, 2026

  • Press releaseBusiness Wire

    Ethisphere Names DocGo as One of the 2026 World's Most Ethical Companies®

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • Press releaseBusiness Wire

    DocGo Announces Fourth Quarter and Full Year 2025 Results

  • Press releasePRNewswire

    Did DocGo Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • Press releaseBusiness Wire

    DocGo to Announce Fourth Quarter and Full Year 2025 Results on Monday, March 16, 2026

  • Press releaseBusiness Wire

    DocGo Announces Upcoming Participation at TD Cowen 46th Annual Health Care Conference

  • Press releaseBusiness Wire

    DocGo's SteadyMD Announces Immediate Expansion of Clinical Workforce to Meet Rising Demand for Branded GLP-1 Weight Loss Care

  • Press releaseBusiness Wire

    DocGo Announces Upcoming Participation at 28th Annual Needham Growth Conference

  • Press releaseBusiness Wire

    Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement in the DocGo Securities Litigation

  • Press releasePRNewswire

    HALPER SADEH LLC ENCOURAGES DOCGO INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

  • Press releaseBusiness Wire

    DocGo Announces Participation at Upcoming December Investor Conferences

  • Press releaseBusiness Wire

    DocGo Announces Participation at Upcoming Investor Conferences

  • Press releaseBusiness Wire

    DocGo Announces Third Quarter 2025 Results

  • Press releaseBusiness Wire

    DocGo Announces Upcoming Launch of Longitudinal Care Services for Major California Health Plan

  • Press releaseBusiness Wire

    DocGo to Announce Third Quarter 2025 Results on Monday, November 10, 2025

  • Press releaseBusiness Wire

    Halper Sadeh LLC Encourages DocGo Inc. Shareholders to Contact the Firm to Discuss Their Rights

  • Press releaseBusiness Wire

    DocGo Acquires Virtual Care Platform SteadyMD, Expands Telehealth Services Across All 50 States

  • Press releaseGlobe Newswire

    Investor Alert: Class Action Lawsuits Against General Motors, DocGo, Estée Lauder, and Axsome Therapeutics Survive Motions to Dismiss — Johnson Fistel, PLLP Encourages Shareholders to Contact the Firm

  • Press releaseBusiness Wire

    DocGo Announces Second Quarter 2025 Results

  • Press releaseGlobe Newswire

    Investor Alert: Class Action Lawsuits Against General Motors, DocGo, Estée Lauder, and Axsome Therapeutics Survive Motions to Dismiss — Johnson Fistel, PLLP Encourages Shareholders to Contact the Firm

  • Press releaseBusiness Wire

    DocGo Announces Fourth Quarter and Full-Year 2024 Results

  • Press releaseBusiness Wire

    DocGo Announces Third Quarter 2024 Results

  • Press releaseBusiness Wire

    DocGo Announces Strong Second Quarter 2024 Results

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.